COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 70 filers reported holding COGENT BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,700,006 | -17.7% | 3,558,975 | 0.0% | 4.18% | -29.7% |
| Q2 2023 | $42,138,264 | +41.5% | 3,558,975 | +29.0% | 5.94% | +16.0% |
| Q1 2023 | $29,769,340 | -6.7% | 2,758,975 | 0.0% | 5.12% | +1.2% |
| Q4 2022 | $31,893,751 | -22.5% | 2,758,975 | 0.0% | 5.06% | -30.1% |
| Q3 2022 | $41,164,000 | +65.4% | 2,758,975 | 0.0% | 7.24% | +27.0% |
| Q2 2022 | $24,886,000 | +113.1% | 2,758,975 | +77.0% | 5.70% | +106.3% |
| Q1 2022 | $11,677,000 | -12.7% | 1,558,975 | 0.0% | 2.76% | -37.4% |
| Q4 2021 | $13,376,000 | +2.0% | 1,558,975 | 0.0% | 4.41% | -7.5% |
| Q3 2021 | $13,111,000 | +3.7% | 1,558,975 | 0.0% | 4.77% | -8.3% |
| Q2 2021 | $12,643,000 | -7.6% | 1,558,975 | 0.0% | 5.20% | -9.9% |
| Q1 2021 | $13,688,000 | -21.8% | 1,558,975 | 0.0% | 5.77% | -7.8% |
| Q4 2020 | $17,507,000 | – | 1,558,975 | – | 6.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,558,975 | $12,643,000 | 5.20% |
| COMMODORE CAPITAL LP | 1,367,582 | $11,091,000 | 3.86% |
| Ghost Tree Capital, LLC | 1,600,000 | $12,976,000 | 3.57% |
| Ally Bridge Group (NY) LLC | 1,622,591 | $13,159,000 | 3.27% |
| Atlas Venture Associates IX, LLC | 916,832 | $7,436,000 | 1.31% |
| VR Adviser, LLC | 1,088,817 | $8,830,000 | 1.07% |
| Logos Global Management LP | 1,420,500 | $11,520,000 | 0.97% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 198,245 | $1,608,000 | 0.72% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $2,658,000 | 0.68% |
| BVF INC/IL | 1,532,282 | $12,427,000 | 0.47% |